ClinicalTrials.govpublic full text
To Evaluate the Clinical Efficacy and Safety of Recombinant Human Interferon ω Spray in Treatment of Viral Upper Respiratory Tract Infection in Children
viral upper respiratory tract infection, recombinant human interferon ω, safety, efficacy, 3-12 years, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 837912
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.